Enrolling
CTNPT 036: Novel Assay for Syphilis
Using a novel assay to detect syphilis infection early in asymptomatic men who have sex with men (MSM) undergoing STI screening
Learn MoreEnrolling
Using a novel assay to detect syphilis infection early in asymptomatic men who have sex with men (MSM) undergoing STI screening
Learn MoreReporting
A pilot study of a novel, mRNA-based assay for the diagnosis of anal HPV infection HIV-positive MSM
Learn MoreCompleted
Can valacylovir attenuate inflammation in ART-treated HIV-infected individuals with herpes simplex virus type 2? Trial results
Learn MoreReporting
Assessing feasibility of collecting repeated blood and swab samples for herpesviruses in HIV-infected individuals hospitalized with acute illness
Learn MoreReporting
Penicillin therapeutic drug monitoring in the treatment of infectious syphilis. Do low serum penicillin concentrations correlate with treatment failure?
Learn MoreCTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.